{"id":177757,"date":"2019-11-25T16:50:13","date_gmt":"2019-11-25T16:50:13","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=177757"},"modified":"2019-11-25T16:50:13","modified_gmt":"2019-11-25T16:50:13","slug":"bristol-myers-squibb-finalizeaza-preluarea-celgene-ca-urmare-a-unei-tranzactii-de-74-mld-dolari","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=177757","title":{"rendered":"Bristol-Myers Squibb finalizeaz\u0103 preluarea Celgene, ca urmare a unei tranzac\u0163ii de 74 mld. dolari"},"content":{"rendered":"<div>\nOdat\u0103 cu finalizarea achizi\u0163iei, \u00een conformitate cu termenii acordului de fuziune, Celgene a devenit o filial\u0103 de\u0163inut\u0103 integral de c\u0103tre Bristol-Myers Squibb Company.&nbsp;<\/div>\n<div>\n<div>\n&nbsp;<\/div>\n<div>\n\u00cen baza fuziunii, ac\u0163ionarii Celgene au primit pentru fiecare ac\u0163iune: 1,00 ac\u0163iune Bristol-Myers Squibb, 50,00 dolari \u00een numerar f\u0103r\u0103 dob\u00e2nd\u0103 \u015fi un drept contingent tranzac\u0163ionabil (Contingent Value Right \/ CVR), care va \u00eendrept\u0103\u0163i posesorul s\u0103 primeasc\u0103 o plat\u0103 de 9,00 dolari \u00een numerar, dac\u0103 se \u00eendeplinesc anumite etape ulterioare de reglementare. Ac\u0163iunile Celgene nu se mai tranzac\u0163ioneaz\u0103 dup\u0103 \u00eenchiderea bursei de ast\u0103zi. \u00cen data de 21 noiembrie 2019, ac\u0163iunile nou emise ale Bristol-Myers Squibb \u015fi CVRurile vor fi tranzac\u0163ionate \u00een cadrul bursei din New York, CVRurile fiind comercializate sub simbolul \u201eBMYRT.\u201d<\/div>\n<div>\n&nbsp;<\/div>\n<div>\nConform inform\u0103rii din 26 august 2019, referitoare la procesul de aprobare a tranzac\u0163iei, Celgene a \u00eencheiat acordul de cesionare a drepturilor interna\u0163ionale asupra medicamentului Otezla c\u0103tre Amgen, pentru 13.4 miliarde dolari \u00een numerar, ca urmare a finaliz\u0103rii fuziunii cu Bristol-Myers Squibb.&nbsp;<\/div>\n<div>\n&nbsp;<\/div>\n<div>\nPe 15 noiembrie 2019, Bristol-Myers Squibb a anun\u0163at decizia Comisiei Federal\u0103 pentru Comer\u0163 a SUA (FTC) de a accepta acordul propus, referitor la fuziunea \u00een curs de finalizare a Bristol-Myers Squibb \u015fi Celgene, ceea ce a permis p\u0103r\u0163ilor s\u0103 \u00eencheie fuziunea. Bristol-Myers Squibb a\u015fteapt\u0103 ca cesionarea OTEZLA s\u0103 fie finalizat\u0103 imediat dup\u0103 \u00eencheierea fuziunii \u015fi planific\u0103 s\u0103 prioritizeze utilizarea \u00eencas\u0103rilor pentru reducerea datoriei.<\/div>\n<\/div>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania Bristol-Myers Squibb a anun\u0163at finalizarea prelu\u0103rii Celgene Corporation, dup\u0103 primirea aprob\u0103rilor necesare din partea tuturor autorit\u0103\u0163ilor guvernamentale prev\u0103zute de c\u0103tre acordul de fuziune \u015fi, conform anun\u0163ului din 12 aprilie 2019, dup\u0103 aprobarea din partea ac\u0163ionarilor Bristol-Myers Squibb \u015fi Celgene.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[457,16199,9319,10146,7518,31857,7128],"class_list":["post-177757","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-acord","tag-anunt","tag-finalizare","tag-fuziune","tag-preluare","tag-primire","tag-tranzactii"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/177757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=177757"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/177757\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=177757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=177757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=177757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}